Mani Foroohar

Work

Analyst Mani Foroohar works at LEERINK and is focused on the Healthcare sector with 405 price targets and ratings documented since 2018 spanning on 25 stocks. Analyst's average stock valuation to be materialised ratio is 34.12% with an average time for price targets to be met of 116.8 days.

Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals, Inc at 23-Jan-2023.

Mani Foroohar best performing recommendations are on FDMT.
The best stock recommendation documented was for FDMT at 11/14/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.51 (11.19%) receiving and performance score of 111.93.

Average potential price target upside

ADVM ALNY ARWR BBIO BLUE CRBU DBTX DRNA IONS MRNA NTLA RCKT RGNX RXRX WVE SRPT ABEO ALVR FDMT MIRM AMYT GRPH TALS EDIT BEAM

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

2

$1.3 (185.71%)

2.5

2 months 26 days ago

0/2 (0%)

$1.13 (114.91%)

Hold

2

$1.3 (185.71%)

5

1 years 6 months 14 days ago

3/5 (60%)

$3.07 (29.73%)

47

Hold

3

$2.3 (328.57%)

21

1 years 6 months 14 days ago

4/5 (80%)

$3.63 (50.89%)

139

Hold

21

1 years 6 months 14 days ago

2/2 (100%)

$7.53 (88.83%)

197

Buy

6

$5.3 (757.14%)

30

1 years 9 months 8 days ago

1/3 (33.33%)

$4.81 (39.30%)

34

Show more analysts
ADVM ALNY ARWR BBIO BLUE CRBU DBTX DRNA IONS MRNA NTLA RCKT RGNX RXRX WVE SRPT ABEO ALVR FDMT MIRM AMYT GRPH TALS EDIT BEAM